ImmunityBio, Inc.
IBRX
$2.51
$0.041.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.91% | -40.19% | 27.85% | -36.02% | 40.39% |
| Total Receivables | -45.90% | 138.06% | -3.60% | -32.54% | 36.26% |
| Inventory | 322.47% | 8.12% | -- | -- | -- |
| Prepaid Expenses | 10.01% | 34.25% | 0.52% | -19.39% | 38.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -33.54% | 10.98% | -18.35% | 12.86% | -18.48% |
| Total Current Assets | 13.14% | -32.81% | 24.07% | -33.45% | 36.73% |
|
|
|||||
| Total Current Assets | 13.14% | -32.81% | 24.07% | -33.45% | 36.73% |
| Net Property, Plant & Equipment | -2.17% | -0.89% | -1.66% | -2.15% | -2.77% |
| Long-term Investments | 0.00% | -- | -- | -- | -- |
| Goodwill | 0.00% | -- | -- | -- | -- |
| Total Other Intangibles | -3.51% | -3.05% | -3.10% | -3.05% | -7.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.64% | 11.04% | 0.12% | -0.70% | -4.57% |
| Total Assets | 5.04% | -17.95% | 10.89% | -20.57% | 16.66% |
|
|
|||||
| Total Accounts Payable | -32.38% | -51.05% | 46.49% | 50.83% | -53.60% |
| Total Accrued Expenses | -4.52% | 17.20% | 10.42% | -22.39% | -32.59% |
| Short-term Debt | -42.30% | -- | -- | -59.59% | -36.91% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.16% | 12.15% | 2.38% | 15.39% | 19.36% |
| Total Finance Division Other Current Liabilities | -24.48% | 28.63% | -33.88% | -10.31% | -45.42% |
| Total Other Current Liabilities | -24.48% | 28.63% | -33.88% | -10.31% | -45.42% |
| Total Current Liabilities | -9.87% | -1.85% | 15.53% | -7.76% | -35.47% |
|
|
|||||
| Total Current Liabilities | -9.87% | -1.85% | 15.53% | -7.76% | -35.47% |
| Long-Term Debt | -23.28% | 1.73% | 12.43% | 1.62% | 24.25% |
| Short-term Debt | -42.30% | -- | -- | -59.59% | -36.91% |
| Capital Leases | -5.27% | 0.92% | -4.64% | -4.36% | 1.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.43% | -56.00% | -41.75% | -3.87% | 289.62% |
| Total Liabilities | -21.44% | -2.89% | 4.58% | 0.12% | 29.34% |
|
|
|||||
| Common Stock & APIC | 12.22% | 1.53% | 5.33% | 1.23% | 2.54% |
| Retained Earnings | -1.78% | -2.65% | -4.35% | -4.53% | -8.55% |
| Treasury Stock & Other | 1,063.11% | 1,387.50% | -14.29% | -170.00% | -98.74% |
| Total Common Equity | 34.36% | -6.70% | -0.92% | -17.89% | -42.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.36% | -6.70% | -0.92% | -17.89% | -42.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.72% | -2.28% | -1.94% | -2.00% | -2.05% |
| Total Equity | 34.41% | -6.71% | -0.93% | -17.93% | -42.69% |
|
|
|||||